Defiance ETFs launches two new 2X leveraged ETFs targeting Rocket Lab and Hims & Hers, amplifying daily stock performance.

Defiance ETFs has introduced two new 2X leveraged single-stock ETFs, RKLX and HIMZ, targeting Rocket Lab and Hims & Hers Health respectively. RKLX aims to double Rocket Lab's daily performance, while HIMZ targets twice the daily return of Hims & Hers. These ETFs offer amplified exposure without needing a margin account but come with higher risks, including potential losses even if the underlying stocks rise.